The Inaugural Market Access for CNS Therapeutics Summit Has Arrived!
The Market Access for CNS Therapeutics Summit is the only dedicated forum focused on tackling the unique commercial and reimbursement challenges facing treatments for neurodegeneration, mental health, neuromuscular disorders, and other complex CNS conditions.
With over 16 expert speakers and in-depth sessions spanning biomarker reimbursement, payer policy alignment, patient access infrastructure, and umbrella trials, this summit provides practical insights for navigating the rising complexity of access in CNS. Topics include how to embed market access early in evidence planning, challenges of payer expectations, and strategic engagement to unlock real-world adoption.
Attendees will hear directly from leaders at Roche, AbbVie, Neurolief, Labcorp, CVS Health, Eli Lilly, and more, covering real-world learnings on formulary access, digital therapeutics, CNS diagnostics, and cross-sector collaborations.
Join biotech and pharma peers, commercial and government payers, healthcare providers, and advocacy groups to inform your strategy, enhance launch readiness, and enable earlier access for patients across the CNS care continuum.
When: September 24-25, 2025
View the full event guide to learn more: https://ter.li/sioas1
